The priming of tumor-specific CD8+ T cells occurs in the lymph nodes by DCs that take up and cross-present neoantigens from the tumor, and activated tumor-specific T cells migrate into tumors guided by cytokine gradients (153, 154). This evidence concerns the gene CD8A and neoplasm.